| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.29 | 3e-09 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.089 | 0.06 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.055 | 0.2 |